<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
87565-0010-1
</NDCCode>
<PackageDescription>
15 mL in 1 PACKAGE (87565-0010-1)
</PackageDescription>
<NDC11Code>
87565-0010-01
</NDC11Code>
<ProductNDC>
87565-0010
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Krx Aesthetics Pd-13 Therapy
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Krx Aesthetics Pd-13 Therapy
</NonProprietaryName>
<DosageFormName>
SPRAY
</DosageFormName>
<RouteName>
TOPICAL
</RouteName>
<StartMarketingDate>
20260101
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
UNAPPROVED DRUG OTHER
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
BY KIN AESTHETICS LLC
</LabelerName>
<SubstanceName>
METHYL AMINOLEVULINATE HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
1.95
</StrengthNumber>
<StrengthUnit>
mg/15mL
</StrengthUnit>
<Pharm_Classes>
Porphyrin Precursor [EPC], Porphyrinogens [CS]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2026-04-02
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20260101
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>